The CLASP III TR CED Study
NCT:NCT07859709 · NOT_YET_RECRUITING
廣告
NCT IDNCT07859709
狀態NOT_YET_RECRUITING
開始日期2026-10-15
完成時間2033-10-31
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated
簡要摘要
This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Repair procedure using the PASCAL Precision system.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。